IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Eyegate Pharmaceuticals Inc

CUSIP: 30233M115 | 12 institutional holders

Quarters

Q2 2020Q1 2020Q4 2019Q3 2019Q2 2019
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2020

AWM Investment Company, Inc.137,092
0.0% of portfolio›$6
Susquehanna International Group, LLP35,621
0.0% of portfolio›$2
UBS Group AG3,508
0.0% of portfolio›$0
Proequities, Inc.0
0.0% of portfolio›$0
StyleTurnoverLocationFiled
AWM Investment Company, Inc.
137,092$60.0%GrowthMediumNew York, NY2020-08-13
Susquehanna International Group, LLP
35,621$20.0%GrowthHighBala Cynwyd, PA2020-08-14
UBS Group AG
3,508$00.0%CoreMediumZurich, Switzerland2020-07-31
Proequities, Inc.
0$00.0%GrowthVery LowBirmingham, AL2020-08-13